Search

Author/Creator Sharfman, William

1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016)

Authors:
Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David; Fradet, Yves; Lee, Jae; Fong, Lawrence
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 2(2016)
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts. Issue 2 (December 2016)

Authors:
Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David; Fradet, Yves; Lee, Jae; Fong, Lawrence
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 2(2016)
Page Start:
223
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016. (8th December 2016)

Authors:
Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze Heng; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David J.; Fradet, Yves; Lee, Jae Lyun; Fo...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 2
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one. Issue 1 (November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy; Sachsenmeier, ...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4:Issue 1(2016)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016)

Authors:
Lundqvist, Andreas; van Hoef, Vincent; Zhang, Xiaonan; Wennerberg, Erik; Lorent, Julie; Witt, Kristina; Sanz, Laia Masvidal; Liang, Shuo; Murray, Shannon; Larsson, Ola; Kiessling, Rolf; Mao, Yumeng; Sidhom, John-William; Bessell, Catherine A.; Havel, Jonathan; Schneck, Jonathan; Chan, Timothy A.;...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 4(2016)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. A first‐in‐human phase I, multicenter, open‐label, dose‐escalation study of the oral RAF/VEGFR‐2 inhibitor (RAF265) in locally advanced or metastatic melanoma independent from BRAF mutation status. (18th July 2017)

Authors:
Izar, Benjamin; Sharfman, William; Hodi, F. Stephen; Lawrence, Donald; Flaherty, Keith T.; Amaravadi, Ravi; Kim, Kevin B.; Puzanov, Igor; Sosman, Jeffrey; Dummer, Reinhard; Goldinger, Simone M.; Lam, Lyhping; Kakar, Shefali; Tang, Zhongwen; Krieter, Oliver; McDermott, David F.; Atkins, Michael B.
Journal:
Cancer medicine
Issue:
Volume 6:Number 8(2017:Aug.)
Page Start:
1904
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. An update on the Society for Immunotherapy of Cancer consensus statement on tumor immunotherapy for the treatment of cutaneous melanoma: version 2.0. Issue 1 (30th May 2018)

Authors:
Sullivan, Ryan J.; Atkins, Michael B.; Kirkwood, John M.; Agarwala, Sanjiv S.; Clark, Joseph I.; Ernstoff, Marc S.; Fecher, Leslie; Gajewski, Thomas F.; Gastman, Brian; Lawson, David H.; Lutzky, Jose; McDermott, David F.; Margolin, Kim A.; Mehnert, Janice M.; Pavlick, Anna C.; Richards, Jon M.; R...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 6:Issue 1(2018)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Neoadjuvant nivolumab for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas of the head and neck in the CheckMate 358 trial. Issue 6 (2nd June 2021)

Authors:
Ferris, Robert L; Spanos, William C; Leidner, Rom; Gonçalves, Anthony; Martens, Uwe M; Kyi, Chrisann; Sharfman, William; Chung, Christine H; Devriese, Lot A; Gauthier, Helene; Chiosea, Simon I; Vujanovic, Lazar; Taube, Janis M; Stein, Julie E; Li, Jun; Li, Bin; Chen, Tian; Barrows, Adam; Topalian...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 9:Issue 6(2021)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Neurologic Serious Adverse Events Associated with Nivolumab Plus Ipilimumab or Nivolumab Alone in Advanced Melanoma, Including a Case Series of Encephalitis. (11th May 2017)

Authors:
Larkin, James; Chmielowski, Bartosz; Lao, Christopher D.; Hodi, F. Stephen; Sharfman, William; Weber, Jeffrey; Suijkerbuijk, Karijn P. M.; Azevedo, Sergio; Li, Hewei; Reshef, Daniel; Avila, Alexandre; Reardon, David A.
Journal:
Oncologist
Issue:
Volume 22:Number 6(2017)
Page Start:
709
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗